A major difficulty in the interpretation of these findings arises from the fact that closed commissurotomy often results in incomplete relief of obstruction, and it is difficult to determine ...

F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach ...

Researchers from the University of Pittsburgh School of Medicine have linked pulmonary arterial hypertension (PAH), a ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Negative-pressure pulmonary edema (NPPE ... 16,653 similar procedures were done during this time. The overall prevalence of NPPE (<0.1%) was not significantly different between male and female ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with ...

PAH is a progressive and life-threatening disease in which the blood pressure ... time, we found that after PAH-targeted therapy, the uptake of 18 F-FAPI in the right heart and pulmonary artery ...